A new treatment that restores the hope of recovery from medicine -resistant tuberculosis patients

Asia and the Pacific countries have begun to adopt a faster and more effective remedy for drug -resistant tuberculosis, giving the hope of a ‘new era’ in the fight against one of the deadliest infectious diseases in the world. According to the World Health Organization, this region sustained the largest percentage of 10.6 million new tuberculosis injuries around the world in 2022, and more than half of the deaths of 1.3 million cases. Despite the possibility of treating tuberculosis with antibiotics, more than 3% of the new people suffering from this infectious disease suffer from a form of medicine resistance. Until recently, treatments have included daily injection or have taken large doses of tablets for at least 18 months, and sometimes with strong side effects, including nausea, in extreme cases, blindness, while many patients have abandoned their treatment for this reason. The presentation of a new lighter treatment has begun with fewer side effects in the region, especially in the Philippines, Vietnam and Indonesia, and experiments have shown that the recovery rate is more than 90% after six months. The BPAL treatment, which combines antibiotics “bidakueline”, “pre -use” and “linzolid”, has been approved in more than 60 countries, according to “TB Anens” (TB Control Alliance), which is a non -profit organization that developed this treatment. As for the Filipine chew, Evanio Brylanti, who suffered from drug -resistant tuberculosis, saved this change, and with his previous treatment he had to swallow 20 tablets a day, but he felt so nauseous that he could not work or eat, and stopped after two weeks, despite the risks. “It’s very difficult, since you are forced to sleep, I sometimes couldn’t even breathe.” The following month, Brylanti participated in the “Pal Pal” experience at Pambanga County Hospital, in the north of the Philippine capital, Manila, with three to seven grains a day. The man was restored after six months and admitted, “If I hadn’t taken this medicine, I would have been in the cemetery now.” Tuberculosis is caused by tuberculosis of bacteria that mainly attack the lungs, and it is transmitted by the air of contaminated people, distributed in different countries of the world, and it mainly affects the poor who live and work in crowded places. In 2022, two -thirds of new cases were monitored in eight countries: India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh and the Democratic Republic of Congo. One of the most important challenges is to persuade patients to complete their treatment, in light of their alienation of the high cost or coercion of travel, or of its side effects. “The vast majority of patients with resistant tuberculosis, in Vietnam, had to resist” catastrophic “expenses to treat them. Other problems; determining patients and fighting negative social stigma, and in Indonesia some health institutions are still unable to diagnose the disease properly, according to Imran Bamboudi. -virus, which disrupted the diagnosis and treatment of the disease. , “Ravkant Singh, founder of the non -governmental organization” doctors “told you.